Showing results (21-30 of 72) with videos related to
Sort By:
Pageof 8
Behavior Modification|May 22, 2012
Using video Social Stories™ to increase task engagement for middle school students with autism spectrum disordersDavid F Cihak, Laura K Kildare, Catherine C Smith, et al.Blood Advances|February 7, 2022
Molecular profile of FLT3-mutated relapsed/refractory patients with AML in the phase 3 ADMIRAL study of gilteritinibCatherine C Smith, Mark J Levis, Alexander E Perl, et al.Blood Advances|February 11, 2020
Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutationsTheodore C Tarver, Jason E Hill, Leena Rahmat, et al.Mutagenesis|February 20, 2008
The comet assay: topical issuesAndrew R Collins, Amaia Azqueta Oscoz, Gunnar Brunborg, et al.Bioinformatics (Oxford, England)|June 5, 2025
SNACS: a tool for demultiplexing single-cell DNA sequencing dataVanessa E Kennedy, Ritu Roy, Cheryl A C Peretz, et al.Nature Communications|March 12, 2021
Joint profiling of DNA and proteins in single cells to dissect genotype-phenotype associations in leukemiaBenjamin Demaree, Cyrille L Delley, Harish N Vasudevan, et al.Journal of Travel Medicine|May 28, 2014
Plasmodium knowlesi: clinical presentation and laboratory diagnosis of the first human case in a Scottish travelerClaire J Cordina, Richard Culleton, Brian L Jones, et al.Molecular Cancer Therapeutics|April 8, 2022
The Irreversible FLT3 Inhibitor FF-10101 Is Active Against a Diversity of FLT3 Inhibitor Resistance MechanismsTimothy T Ferng, Daisuke Terada, Makoto Ando, et al.Blood|February 23, 2013
Activity of ponatinib against clinically-relevant AC220-resistant kinase domain mutants of FLT3-ITDCatherine C Smith, Elisabeth A Lasater, Xiaotian Zhu, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 29, 2013
Association of age-dependent liver injury and fibrosis with immune cell populationsBradley H Collins, Zoie E Holzknecht, Kellie A Lynn, et al.Pageof 8